文献速递淋巴瘤

S1PR1驱动前馈信号环路调控BATF3及霍奇金淋巴瘤细胞的转录程序

S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.
PubMed 文献 · Leukemia · 2017-09-07

经典型霍奇金淋巴瘤(HL)的Hodgkin/Reed-Sternberg(HRS)细胞存在多条信号通路异常激活。本研究发现部分HL中1-磷酸鞘氨醇(S1P)受体表达改变,S1P通过S1PR1表达升高和S1PR2表达降低介导磷脂酰肌醇3-激酶(PI3-K)激活。PI3-K通路调控的基因与原发性HRS细胞转录程序显著重叠,包括上调BATF3;免疫组化证实大多数HL病例的HRS细胞表达BATF3,而正常淋巴组织中BATF3仅局限于小部分CD30阳性免疫母细胞。敲低BATF3可影响HRS细胞转录程序,包括下调S1PR1。作者认为破坏这一潜在致癌性前馈S1P信号环路可能为HL患者提供新的治疗机会。

要点

  • 部分HL中S1PR1表达升高、S1PR2表达降低,介导S1P激活PI3-K。
  • PI3-K通路上调的基因与原发性HRS细胞转录程序显著重叠,包括BATF3。
  • 大多数HL病例HRS细胞表达BATF3,正常淋巴组织中仅小部分CD30阳性免疫母细胞表达。

核心结论

  • 数据提示破坏这一潜在致癌性前馈S1P信号环路可能为HL患者提供新的治疗机会。

研究设计与样本

  • 研究使用HL细胞系并结合原发性HRS细胞转录程序分析,具体样本量与设计类型原文未报告。

主要发现

  • 部分HL显示S1P受体表达改变,S1P通过S1PR1表达升高和S1PR2表达降低介导PI3-K激活。
  • PI3-K通路调控的基因与原发性HRS细胞转录程序显著重叠,上调基因包括BATF3。
  • 免疫组化证实大多数HL病例的HRS细胞表达BATF3,正常淋巴组织中BATF3仅限于小部分CD30阳性免疫母细胞。
  • 敲低BATF3显示其参与原发性HRS细胞转录程序,包括上调S1PR1。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma (HL) are characterised by the aberrant activation of multiple signalling pathways. Here we show that a subset of HL displays altered expression of sphingosine-1-phosphate (S1P) receptors (S1PR)s. S1P activates phosphatidylinositide 3-kinase (PI3-K) in these cells that is mediated by the increased expression of S1PR1 and the decreased expression of S1PR2. We also showed that genes regulated by the PI3-K signalling pathway in HL cell lines significantly overlap with the transcriptional programme of primary HRS cells. Genes upregulated by the PI3-K pathway included the basic leucine zipper transcription factor, ATF-like 3 (BATF3), which is normally associated with the development of dendritic cells. Immunohistochemistry confirmed that BATF3 was expressed in HRS cells of most HL cases. In contrast, in normal lymphoid tissues, BATF3 expression was confined to a small fraction of CD30-positive immunoblasts. Knockdown of BATF3 in HL cell lines revealed that BATF3 contributed to the transcriptional programme of primary HRS cells, including the upregulation of S1PR1. Our data suggest that disruption of this potentially oncogenic feedforward S1P signalling loop could provide novel therapeutic opportunities for patients with HL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Vrzalikova K, Ibrahim M, Vockerodt M, et al. S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells. Leukemia. 2017. PMID: 28878352. doi:10.1038/leu.2017.275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。